ExecutiveOrdersEO

Policy → market

Market alerts

Not financial advice

Commercial cliffs from presidential documents — role pressure, mechanisms, and a curated issuer watchlist. Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

How this works
  1. Cliff vs glide — dates that change market access differ from multi-year programs.
  2. Role pressure — protective / adverse / mixed for supply-chain roles (not a stock tip).
  3. Named issuers — curated watchlist only.
  4. Price window — optional EOD chart around issue and cliff dates; coincidence, not causation.
Clear
  1. in 40dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    Tariffs effective for other companies

    ProtectiveAdverseMixed
    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  2. in 884dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    Zero tariff rate expires for companies with MFN pricing agreements

    ProtectiveAdverseMixed
    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  3. in 1321dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    20% onshoring rate increases to 100%

    ProtectiveAdverseMixed
    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
Policy market alerts · Executive Orders